Concepedia

Anthony L. Handlon

AL

14

Publications

517

Citations

13

H-Index

1988

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

Anthony L. Handlon is an author at GlaxoSmithKline (United States) specializing in natural sciences, pharmacology, and biochemistry.

ORCID

Top concepts

Publications per year

1988–2019

14

Publications

14

Cholestyramine Reverses Hyperglycemia and Enhances Glucose-Stimulated Glucagon-Like Peptide 1 Release in Zucker Diabetic Fatty Rats

Lihong Chen, Judi A. McNulty, Don L. Anderson et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 75 citations

Thiol Reduction of 3′-Azidothymidine to 3′-Aminothymidine: Kinetics and Biomedical Implications

Anthony L. Handlon, Norman J. Oppenheimer · Pharmaceutical Research · 1988 · 55 citations

Synthesis and SAR of Benzisothiazole- and Indolizine-β-<scp>d</scp>-glucopyranoside Inhibitors of SGLT2

Huiqiang Zhou, Dana P. Danger, Steven T. Dock et al. · ACS Medicinal Chemistry Letters · 2010 · 51 citations · Full text

Sodium glucose co-transporter 2 (SGLT2) inhibitors as potential antidiabetic agents

Anthony L. Handlon · Expert Opinion on Therapeutic Patents · 2005 · 47 citations

, , +15

The discovery and optimization of pyrimidinone-containing MCH R1 antagonists

Donald L. Hertzog, Kamal Albarazanji, Eric C. Bigham et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 47 citations · Full text

, , +3

Rows per page

1–5 of 14